Test–retest repeatability of [18F]Flortaucipir PET in Alzheimer’s disease and cognitively normal individuals

Longitudinal tau accumulation and atrophy in aging and alzheimer disease

(2019) Theresa M. Harrison et al.   ANNALS OF NEUROLOGY

Longitudinal tau PET in ageing and Alzheimer’s disease

(2018) Clifford R Jack et al.   BRAIN

Amsterdam Dementia Cohort: Performing Research to Optimize Care

(2018) Wiesje M. van der Flier et al.   JOURNAL OF ALZHEIMERS DISEASE

Effects of Hypoperfusion in Alzheimer's Disease

(2018) Benjamin P. Austin et al.   JOURNAL OF ALZHEIMERS DISEASE

A novel partial volume correction method for accurate quantification of [18F] flortaucipir in the hippocampus

(2018) Emma E. Wolters et al.   EJNMMI Research

Forward to the Past: The Case for Quantitative PET Imaging

(2017) Adriaan A. Lammertsma   JOURNAL OF NUCLEAR MEDICINE

Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity

(2017) Sudeepti Southekal et al.   JOURNAL OF NUCLEAR MEDICINE

Test–Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18

(2017) Michael D. Devous et al.   JOURNAL OF NUCLEAR MEDICINE

Quantification of Tau Load Using [18F]AV1451 PET

(2017) Sandeep S. V. Golla et al.   MOLECULAR IMAGING AND BIOLOGY

Differential effects of cognitive reserve and brain reserve on cognition in Alzheimer disease

(2017) Colin Groot et al.   NEUROLOGY

Arterial Spin Labeling Blood Flow MRI: Its Role in the Early Characterization of Alzheimer's Disease

(2017) David C. Alsop et al.   JOURNAL OF ALZHEIMERS DISEASE

A simulation study on the impact of the blood flow-dependent component in [18F]AV45 SUVR in Alzheimer’s disease

(2017) Julie Ottoy et al.   PLoS One

Kinetic Modeling of the Tau PET Tracer 18 F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects

(2016) Olivier Barret et al.   JOURNAL OF NUCLEAR MEDICINE

Pharmacokinetic Evaluation of the Tau PET Radiotracer 18 F-T807 ( 18 F-AV-1451) in Human Subjects

(2016) Dustin W. Wooten et al.   JOURNAL OF NUCLEAR MEDICINE

Alzheimer's disease

(2016) Philip Scheltens et al.   LANCET

Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue

(2015) Marta Marquié et al.   ANNALS OF NEUROLOGY

Retrospective quality control review of FDG scans in the imaging sub-study of PALETTE EORTC 62072/VEG110727: a randomized, double-blind, placebo-controlled phase III trial

(2015) Ivalina Hristova et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Quantification of Blood Flow-Dependent Component in Estimates of Beta-Amyloid Load Obtained Using Quasi-Steady-State Standardized Uptake Value Ratio

(2015) Zsolt Cselényi et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Parametric imaging and quantitative analysis of the PET amyloid ligand [ 18 F]flutemetamol

(2015) Kerstin Heurling et al.   NEUROIMAGE

Quantitative imaging of protein targets in the human brain with PET

(2015) Roger N Gunn et al.   PHYSICS IN MEDICINE AND BIOLOGY

[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease

(2013) Chun-Fang Xia et al.   Alzheimers & Dementia

Longitudinal Amyloid Imaging Using 11C-PiB: Methodologic Considerations

(2013) B. N. M. van Berckel et al.   JOURNAL OF NUCLEAR MEDICINE

Amyloid imaging in clinical trials

(2013) Rik Ossenkoppele et al.   Alzheimers Research & Therapy

Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease

(2013) Rik Vandenberghe et al.   NeuroImage-Clinical

Cerebral Blood Flow Measured with 3D Pseudocontinuous Arterial Spin-labeling MR Imaging in Alzheimer Disease and Mild Cognitive Impairment: A Marker for Disease Severity

(2012) Maja A. A. Binnewijzend et al.   RADIOLOGY

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

Day-to-Day Test–Retest Variability of CBF, CMRO2, and OEF Measurements Using Dynamic 15O PET Studies

(2010) Jochem P. Bremmer et al.   MOLECULAR IMAGING AND BIOLOGY

Alzheimer's Disease

(2010) Henry W. Querfurth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Test-retest variability of quantitative [11C]PIB studies in Alzheimer’s disease

(2009) Nelleke Tolboom et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING